IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Medical alertness in the treatment of patients with pulmonary tuberculosis without bacteriological and histological confirmation of the diagnosis

Author: N.A. SAMORODOV, ZH.KH. SABANCHIEVA, L.B. TLAPSHOKOVA, M.ZH. CHOCHAEVA, KH.A. SABANCHIEVA, M.H. TLAKADUGOVA, A.M. SHOMAKHOVA, S.KH. SIZHAZHEVA
Abstract: Execution responcible biopsy of the lung first diagnosed tuberculosis with negative results of bacteriological and histological examination (ICD-10, A16.0) made it possible to get a usable studies (biological and morphological) material in 100% of cases. In 63,0% of cases, the application of this technique made it possible to verify the diagnosis, including: bacteriologically – in 42,3%, histologically – in 37,8%, bacteriologically and histologically – in 17,1% of cases. At the same time, confirmation of the diagnosis of tuberculosis was obtained in 41.9% of cases, including: only bacteriologically – in 35.4%, only histologically – in 0.4%, bacteriologically and histologically – in 6.1% of cases. Nontubercular pathology (erroneous diagnosis) was detected in 23.6% of cases (58 patients), more than half of them (33 patients) – malignant tumors of the lung, which emphasizes the importance of responcible biopsy of the lung in this category of patients as early as possible after diagnosis. These data confirm the need and the possibility of using responcible biopsy of the lung in the algorithm of examination of this category of patients to verify the diagnosis and identify patients with non-tuberculous pathology of the lungs.
Keyword: first-diagnosed TB patients; responcibly lung biopsy.
DOI: https://doi.org/10.31838/ijpr/2019.11.03.099
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477